| SapC-DOPS–a Phosphatidylserine-targeted Nanovesicle for selective Cancer therapy KF N’Guessan, PH Patel, X Qi Cell Communication and Signaling 18, 1-5, 2020 | 30 | 2020 |
| The impact of human pegivirus on CD4 cell count in HIV-positive persons in Botswana KF N’Guessan, M Anderson, B Phinius, S Moyo, A Malick, T Mbangiwa, ... Open forum infectious diseases 4 (4), ofx222, 2017 | 18 | 2017 |
| Enhanced efficacy of combination of gemcitabine and phosphatidylserine-targeted nanovesicles against pancreatic cancer KF N’Guessan, HW Davis, Z Chu, SD Vallabhapurapu, CS Lewis, ... Molecular Therapy 28 (8), 1876-1886, 2020 | 16 | 2020 |
| Anti-HIV antibody development up to 1 year after antiretroviral therapy initiation in acute HIV infection JL Mitchell, J Pollara, K Dietze, RW Edwards, J Nohara, KF N’guessan, ... The Journal of clinical investigation 132 (1), 2022 | 11 | 2022 |
| Human pegivirus (HPgV) infection in Ghanaians co-infected with human immunodeficiency virus (HIV) and hepatitis B virus (HBV) KF N’Guessan, C Boyce, A Kwara, TNA Archampong, M Lartey, ... Virus Genes 54, 361-367, 2018 | 11 | 2018 |
| Effect of Passive Administration of Monoclonal Antibodies Recognizing Simian Immunodeficiency Virus (SIV) V2 in CH59-Like Coil/Helical or β-Sheet Conformations on Time of … JD Stamos, MA Rahman, G Gorini, I Silva de Castro, M Becerra-Flores, ... Journal of Virology 97 (4), e01864-22, 2023 | 2 | 2023 |
| Electric Fields Regulate In Vitro Surface Phosphatidylserine Exposure of Cancer Cells via a Calcium-Dependent Pathway A Kaynak, KF N’Guessan, PH Patel, JH Lee, AB Kogan, DA Narmoneva, ... Biomedicines 11 (2), 466, 2023 | 2 | 2023 |
| Innate immune cell activation after HIV-1 vaccine administration is associated with increased antibody production KF N’guessan, K Machmach, I Swafford, MC Costanzo, L Wieczorek, ... Frontiers in Immunology 15, 1339727, 2024 | | 2024 |
| In Vivo Treatment with Insulin-like Growth Factor 1 Reduces CCR5 Expression on Vaccine-Induced Activated CD4+ T-Cells M Bissa, V Galli, L Schifanella, M Vaccari, MA Rahman, G Gorini, ... Vaccines 11 (11), 1662, 2023 | | 2023 |
| Enhanced efficacy of combination of gemcitabine and phosphatidylserine-targeted nanovesicles against pancreatic cancer X Qi, KF N'guessan US Patent App. 17/908,745, 2023 | | 2023 |
| Cholera toxin B scaffolded, focused SIV V2 epitope elicits antibodies that influence the risk of SIVmac251 acquisition in macaques MA Rahman, M Becerra-Flores, Y Patskovsky, I Silva de Castro, M Bissa, ... Frontiers in Immunology 14, 1139402, 2023 | | 2023 |
